Symbol: |
NLGN4X
|
Description: |
neuroligin 4, X-linked [Source:HGNC Symbol;Acc:14287]
|
Location: |
ChrX:5758678-6146904[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:183
Gene |
Compound |
Gen_sig |
Exp_pattern |
NLGN4X |
(Thiopen-2-ylmethylene-hydrazinocarbonylmethylsulfanyl) acetic acid(thiopen-2-ylmethylene)-hydrazide |
0.025 |
Up |
NLGN4X |
S-(dimethylarsino)-3-mercapto-1,2-propyl dibenzoate |
0.006 |
Up |
NLGN4X |
NSC 724771 |
0.002 |
Up |
NLGN4X |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.039 |
Up |
NLGN4X |
Waol A FD-211 |
0.037 |
Up |
NLGN4X |
Everolimus |
0.022 |
Down |
NLGN4X |
NSC 734201 |
0.021 |
Down |
NLGN4X |
Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
0.001 |
Down |
NLGN4X |
4-[(Z)-2-(5-nitro-2-furyl)ethenyl]-6-(4-phenylpiperazin-1-yl )-1,3,5-triazin-2-ylamine |
0.014 |
Up |
NLGN4X |
6-(10'-tert-BOC-aminodecyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.026 |
Down |
NLGN4X |
6-(10'-tert-BOC-aminododecyl)-5,6-dihydro-5,11-dioxo-11H-indeno-[1,2-c]isoquinoline |
0.042 |
Down |
NLGN4X |
6-(3-Azidopropyl)-5,6-dihydro-9-methoxycarbonyl-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.001 |
Down |
NLGN4X |
NSC 740986 |
0.025 |
Down |
NLGN4X |
NSC 741354 |
0.003 |
Up |
NLGN4X |
NSC 742162 |
0.007 |
Down |
Expression pattern: Sensitivity / Resistance
Total:13 Current:12
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:41
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:46
Total:4 Current:1
[First] [Prev]  Next Last 
|